Aug 6

Life Sciences Outlook: From AI Headlines to Real-World Results

PR Insights Template for Website

For much of the past two years, the market's attention has been drawn to the companies building artificial intelligence. Increasingly, however, investors are turning their attention to the companies applying it. 

 

In the life sciences sector, AI is becoming a practical tool used to accelerate drug discovery, improve clinical trial design, and enhance research productivity. While the technology continues to generate headlines, the more important investment question may be around which organizations can translate these capabilities into measurable business outcomes.

 

These themes were reflected in recent commentary from Eric Shrayer, Partner and Director of Research at Reynders, McVeigh Capital Management, in a conversation with Investing News Network. He noted that investor attention may be shifting from companies viewed primarily as AI investments toward businesses demonstrating tangible benefits from AI adoption.  

 

“There are concerns that we're in an AI bubble, and I think money is starting to go from companies that are seen as pure AI plays into companies that can benefit from the adoption of AI,” Shrayer told Investing News Network.

 

Life sciences may be one of the clearest examples of that shift, as AI capabilities move from promise to practical application. At Reynders, McVeigh this reinforces a principle that guides our research approach: technological breakthroughs are important, yet long-term outcomes are often determined by a company's ability to deploy those innovations effectively, allocate capital thoughtfully, and build sustainable business models around them.

 

The next chapter of AI in life sciences may not be defined by the companies generating the most headlines. It may be shaped by those quietly applying technology to solve meaningful problems, improve efficiency, and create lasting value over time.  

 

For additional perspective, read the full article: Biotech and Pharma Market Trends: Q2 2026 Review and Forecast

 

 

DISCLOSURES:

Reynders, McVeigh Capital Management, LLC ("RMCM") is a registered investment adviser. Registration with the U.S. Securities and Exchange Commission does not imply a certain level of skill or training.

The commentary provided is for informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Any companies or investments referenced are presented solely as illustrative examples of the themes discussed and do not represent all securities purchased, sold, or recommended for advisory clients. It should not be assumed that any investment in such companies has been or will be profitable. A complete list of RMCM's recommendations over the past 12 months is available upon request.

By clicking the link above, you are leaving the RMCM website and entering a third-party site. RMCM is not responsible for the accuracy or content of information contained on third-party sites.

 

 

 

© Reynders, McVeigh Capital Management
10 Post Office Square, Suite N1010
Boston, MA 02109

Phone: 617.226.9999
Fax: 617.226.9998

Important disclosures. Views expressed within Insights are those of the authors as of the time of publication; such views are subject to change at any time based on market or other conditions. These views are not intended to be a forecast of future events or a guarantee of future results and may not be relied upon as investment advice. The information contained herein has been prepared from sources believed reliable but is not guaranteed by us as to its timeliness or accuracy, and is not a complete summary or statement of all available data. This is not a recommendation to buy or sell the securities mentioned. Any securities mentioned were selected on an objective basis for illustrative purposes and do not represent all of the securities purchased, sold or recommended. It should not be assumed that investments in any securities mentioned has been or will be profitable. The securities do not represent all of the securities purchased, sold or recommended for advisory clients.Past performance is no guarantee of future results. Every investment carries the potential for both profit and loss.
Past performance is no guarantee of future results. Every investment carries the potential for both profit and loss.
By clicking on hyperlinks, you are leaving the Reynders, McVeigh website and entering a third-party site. Reynders, McVeigh is not responsible for information contained on the third-party sites.